• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Florida Blue enhances cancer care for thousands of members

    12/18/24 4:05:00 PM ET
    $TOI
    Medical/Nursing Services
    Health Care
    Get the next $TOI alert in real time by email

    JACKSONVILLE, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Florida Blue, the state's leading health insurer, has launched a new comprehensive oncology care model designed to provide faster access to high-quality cancer care for its myBlue members. This patient-centric program, jointly developed by Florida Blue, Sanitas Medical Centers, and The Oncology Institute (TOI), is available in select areas across Florida and may grow over time to reach more communities in the state.

    The Oncology Institute, one of Florida Blue's trusted in-network providers and the leading value-based oncology group in the U.S., offers high-quality cancer care in 14 locations in Central and South Florida. Sanitas Medical Centers provides value-based, comprehensive primary care for nearly half a million Florida Blue members, through their 60 Florida Blue | Sanitas Medical Center locations across Florida.

    Through this new program, myBlue members diagnosed with cancer will be quickly connected with their own TOI oncology team, which will develop personalized, evidence-based treatment plans based on the patients' needs and preferences and will partner with their Sanitas primary care provider to actively support each patient's overall health and mental well-being. This collaborative approach ensures seamless communication and coordination between primary care physicians, oncologists and patients and their family members for more comprehensive and integrated care.

    "We are committed to making affordable health care easier and more accessible for our members and our patients," said Elana Schrader, senior vice president, Health Care Services at Florida Blue, and president of GuideWell Health. "This program is an example of how we're transforming the system to deliver value-based care solutions that improve health outcomes and help keep care more affordable. Together with The Oncology Institute and Sanitas, we're able to begin offering myBlue members rapid access to high-quality cancer care, while also empowering the Sanitas primary care team to manage their overall health and well-being during a critical and often stressful time for patients and their families."

    Dr. Raul Daza, chief medical officer for Sanitas, added, "We are confident that through our collaboration with The Oncology Institute our patients will have a better overall care experience and clearer communications as they deal with a disease state that can be challenging and complicated to understand. By partnering with TOI, we are taking proactive steps toward providing the support cancer patients require, which can also include other physical, mental and social needs that are critical to help them comply with their treatment. We believe this partnership will set a new standard for oncology care."

    myBlue is a popular Florida Blue health insurance plan for individuals and families who buy their own coverage (not provided by employer group coverage) designed to provide access to affordable and convenient health care through a network of trusted providers, like Sanitas Medical Centers. As an HMO plan, it is centered around the member and the primary care doctor who coordinates all of the patient's health care needs.

    Individuals who are not currently myBlue members can enroll during the current Marketplace open enrollment period which ends on Jan. 15, or anytime during the year if they qualify for a special enrollment. For more information, please visit FloridaBlue.com/MarketplaceEnrollment or call 1-800-876-2227.

    About Florida Blue  

    Florida Blue, the leading health insurer in Florida, has been providing health solutions to residents of Florida for more than 80 years. Driven by its mission of helping people and communities achieve better health, the company serves more than six million members and all 67 Florida counties. Headquartered in Jacksonville, Fla., with more than 9,000 employees, it is an independent licensee of the Blue Cross Blue Shield Association.

    For additional information visit www.FloridaBlue.com. For the latest news and content, visit the Florida Blue Newsroom, and follow Florida Blue on Facebook, LinkedIn, and Instagram @Florida.Blue; and X (formerly Twitter) @FLBlue.

    About Florida Blue | Sanitas Medical Centers

    Sanitas Medical Centers is a joint venture between two leading health care organizations – GuideWell Mutual Holding Company and Organización Sanitas Internacional, now under the Keralty brand. GuideWell is a U.S.-based not-for-profit mutual holding company and the parent to a family of forward-thinking companies focused on transforming health care. Keralty is a leading multinational health organization serving more than 10.5 million people with presence in the United States, Colombia, Middle East, Mexico, Brazil, Spain, Peru, Venezuela, Philippines, Dominican Republic and Puerto Rico. The companies are collaborating to expand access to high quality and culturally relevant health care in the United States. Find out more at www.MySanitas.com.

    About GuideWell

    GuideWell comprises Florida's Blue Cross Blue Shield plan, Florida Blue, which is the leading health insurer in Florida; Triple-S Management, Puerto Rico's Blue Cross Blue Shield plan and a leading health care services company on the island; GuideWell Health, a portfolio of integrated care delivery organizations providing primary and urgent care at nearly 100 Florida medical centers and affiliate clinics, which includes Florida Blue | Sanitas Medical Centers; Emcara Health, which partners with primary care providers to extend care into the home; GuideWell Source, which provides administrative services to federal health care programs; and WebTPA, a market leading administrator of self-funded employer health plans. The company holds majority or significant interests in a range of health solutions companies including Lucet, a behavioral health care company that provides technology-enabled support to payers, providers, and health plan members.

    GuideWell serves 38.5 million people across 50 states, Puerto Rico and the U.S. Virgin Islands, including more than 6 million individuals in Florida.

    For additional information visit www.GuideWell.com. For details regarding the company's community and sustainability efforts, read the GuideWell Impact Report. For the latest news and content, visit the GuideWell Newsroom, and follow GuideWell on Facebook, LinkedIn, Instagram @LifeAtGuideWell, and X @_GuideWell.

    About The Oncology Institute

    Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

    Media

    The Oncology Institute, Inc.

    Daniel Virnich, MD

    [email protected]

    (562) 735-3226 x 81125

    Revive

    Michael Petrone

    [email protected]

    (615) 760-4542

    Investors

    Solebury Strategic Communications

    [email protected]



    Primary Logo

    Get the next $TOI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TOI

    DatePrice TargetRatingAnalyst
    11/25/2025$5.00Buy
    Needham
    7/23/2025$8.00Outperform
    Noble Capital Markets
    7/16/2025$6.00Buy
    B. Riley Securities
    5/15/2025$7.00Buy
    BTIG Research
    2/26/2024$2.50Buy
    Jefferies
    9/14/2022$7.00Buy
    Guggenheim
    8/15/2022$10.00Buy
    Jefferies
    More analyst ratings

    $TOI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

    CERRITOS, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI)  a pioneer in value-based community oncology care, today announced that the company will release its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13758646. The

    2/26/26 8:00:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March

    CERRITOS, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI), a pioneer in value-based community oncology care, today announced that members of its executive leadership team will participate in several investor conferences in March. Details for the conferences are as follows: Jefferies Healthcare Services Innovation & Technology SummitPresentation: Monday, March 9, 2026, from 11:30 a.m. to 12:00 p.m. ETLocation: Miami, FLPresenter: Dr. Daniel Virnich, Chief Executive OfficerLeerink Global Healthcare ConferencePresentation: Monday, March 9, 2026, from 3:00 p.m. to 3:30 p.m. ETLocation: Miami, FLPresenter: Rob Carter, Chief Financial OfficerOppenheimer 36th

    2/25/26 8:00:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute Appoints Kim Tzoumakas to Board of Directors

    CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced the appointment of Kim Tzoumakas to its Board of Directors, effective February 23, 2026. Ms. Tzoumakas brings more than two decades of executive leadership experience across oncology, pharmacy services and healthcare operations. Notably, she is Chief Executive Officer for VytlOne National Pharmacy Services, and previously held the CEO role at 21st Century Oncology, where she successfully led the organization through a multi-year operational turnaround, culminating in its strategic sale. She also has serve

    2/23/26 8:00:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $TOI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on The Oncology Institute with a new price target

    Needham initiated coverage of The Oncology Institute with a rating of Buy and set a new price target of $5.00

    11/25/25 8:00:05 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Noble Capital Markets initiated coverage on The Oncology Institute with a new price target

    Noble Capital Markets initiated coverage of The Oncology Institute with a rating of Outperform and set a new price target of $8.00

    7/23/25 9:21:53 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    B. Riley Securities initiated coverage on The Oncology Institute with a new price target

    B. Riley Securities initiated coverage of The Oncology Institute with a rating of Buy and set a new price target of $6.00

    7/16/25 7:58:29 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $TOI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Stolper Mark

    3 - Oncology Institute, Inc. (0001799191) (Issuer)

    1/12/26 4:57:19 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Amendment: Chief Financial Officer Carter Robert Ross disposed of $895 worth of shares (244 units at $3.67), decreasing direct ownership by 0.10% to 235,125 units (SEC Form 4)

    4/A - Oncology Institute, Inc. (0001799191) (Issuer)

    1/6/26 4:30:02 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Carter Robert Ross sold $879 worth of shares (247 units at $3.56), decreasing direct ownership by 0.10% to 235,122 units (SEC Form 4)

    4 - Oncology Institute, Inc. (0001799191) (Issuer)

    1/5/26 5:04:59 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $TOI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $TOI
    SEC Filings

    View All

    Amendment: Director Hively Brad bought $47,168 worth of shares (45,280 units at $1.04), increasing direct ownership by 7% to 712,033 units (SEC Form 4)

    4/A - Oncology Institute, Inc. (0001799191) (Issuer)

    4/28/25 7:20:14 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Virnich Daniel bought $23,584 worth of shares (22,640 units at $1.04), increasing direct ownership by 3% to 724,363 units (SEC Form 4)

    4 - Oncology Institute, Inc. (0001799191) (Issuer)

    3/28/25 5:50:27 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Chief Medical Officer Podnos Yale bought $9,434 worth of shares (9,056 units at $1.04), increasing direct ownership by 13% to 79,049 units (SEC Form 4)

    4 - Oncology Institute, Inc. (0001799191) (Issuer)

    3/28/25 5:48:39 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    8-K - Oncology Institute, Inc. (0001799191) (Filer)

    2/23/26 4:44:16 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute Inc. filed SEC Form 8-K: Results of Operations and Financial Condition

    8-K - Oncology Institute, Inc. (0001799191) (Filer)

    1/12/26 8:00:43 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    8-K - Oncology Institute, Inc. (0001799191) (Filer)

    1/7/26 5:02:33 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $TOI
    Leadership Updates

    Live Leadership Updates

    View All

    The Oncology Institute Appoints Kim Tzoumakas to Board of Directors

    CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced the appointment of Kim Tzoumakas to its Board of Directors, effective February 23, 2026. Ms. Tzoumakas brings more than two decades of executive leadership experience across oncology, pharmacy services and healthcare operations. Notably, she is Chief Executive Officer for VytlOne National Pharmacy Services, and previously held the CEO role at 21st Century Oncology, where she successfully led the organization through a multi-year operational turnaround, culminating in its strategic sale. She also has serve

    2/23/26 8:00:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute Announces Addition of Board Member Mark Stolper

    CERRITOS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Mark Stolper has joined the Board of Directors, effective January 2, 2026. Mr. Stolper brings significant public markets, financial and operational leadership experience to The Oncology Institute's board. Mr. Stolper serves as Executive Vice President and Chief Financial Officer of RadNet, Inc. (NASDAQ:RDNT), a position he has held since 2004. Mr. Stolper has also been a member of the Board of Directors of various publicly traded and privately held healthcare companies, including 21st Century Oncolog

    1/5/26 8:30:00 AM ET
    $RDNT
    $TOI
    Medical Specialities
    Health Care
    Medical/Nursing Services

    The Oncology Institute Announces Resignation of Board Member Gabe Ling

    CERRITOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Gabe Ling has resigned from the Board of Directors, effective December 1, 2025. A formal search process has been initiated to add new independent directors with complementary healthcare, clinical, and value-based care expertise. "On behalf of the Board of Directors, I want to thank Gabe for his service during an important chapter in The Oncology Institute's development," said Anne McGeorge, Chairman of the Board. "We appreciate the contributions he made throughout his time on the Board and the valua

    12/1/25 8:30:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $TOI
    Financials

    Live finance-specific insights

    View All

    The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

    CERRITOS, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI)  a pioneer in value-based community oncology care, today announced that the company will release its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13758646. The

    2/26/26 8:00:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

    CERRITOS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended September 30, 2025 and updated its full year 2025 guidance. Recent Operational Highlights Fee-for-service revenue growth of 13% over Q3 2024, driven by continued organic growth performance in Florida and Oregon.Retail Pharmacy and Dispensary set fill records, contributing $75.9 million in revenue and $12.8 million in gross profit in Q3. Signed several new in-network MSO providers in the Florida market and opened our new TOI pharmacy

    11/13/25 4:05:00 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call

    CERRITOS, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI),  a pioneer in value-based community oncology care, today announced that the company will release its third quarter 2025 financial results after the market close on Thursday, November 13, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 1

    10/22/25 4:47:31 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $TOI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Oncology Institute Inc.

    SC 13D/A - Oncology Institute, Inc. (0001799191) (Subject)

    8/20/24 8:20:55 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    SEC Form SC 13D/A filed by The Oncology Institute Inc. (Amendment)

    SC 13D/A - Oncology Institute, Inc. (0001799191) (Subject)

    1/2/24 5:06:50 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by The Oncology Institute Inc. (Amendment)

    SC 13G/A - Oncology Institute, Inc. (0001799191) (Subject)

    7/10/23 10:20:11 AM ET
    $TOI
    Medical/Nursing Services
    Health Care